• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗心律失常药物NIP-142对卡巴胆碱诱导的心房动作电位缩短和GIRK1/4通道的阻断作用。

Blockade by NIP-142, an antiarrhythmic agent, of carbachol-induced atrial action potential shortening and GIRK1/4 channel.

作者信息

Matsuda Tomoyuki, Ito Mie, Ishimaru Sayoko, Tsuruoka Noriko, Saito Tomoaki, Iida-Tanaka Naoko, Hashimoto Norio, Yamashita Toru, Tsuruzoe Nobutomo, Tanaka Hikaru, Shigenobu Koki

机构信息

Department of Pharmacology, Toho University Faculty of Pharmaceutical Sciences, Funabashi, Chiba, Japan.

出版信息

J Pharmacol Sci. 2006 Aug;101(4):303-10. doi: 10.1254/jphs.fp0060324. Epub 2006 Aug 5.

DOI:10.1254/jphs.fp0060324
PMID:16891768
Abstract

Mechanisms for the atria-specific action potential-prolonging action of NIP-142 ((3R*,4S*)-4-cyclopropylamino-3,4-dihydro-2,2-dimethyl-6-(4-methoxyphenylacetylamino)-7-nitro-2H-1-benzopyran-3-ol), a benzopyran compound that terminates experimental atrial arrhythmia, was examined. In isolated guinea-pig atrial tissue, NIP-142 reversed the shortening of action potential duration induced by either carbachol or adenosine. These effects were mimicked by tertiapin, but not by E-4031. NIP-142 concentration-dependently blocked the human G protein-coupled inwardly rectifying potassium channel current (GIRK1/4 channel current) expressed in HEK-293 cells with an EC50 value of 0.64 microM. At higher concentrations, NIP-142 blocked the human ether a go-go related gene (HERG) channel current with an EC50 value of 44 microM. In isolated guinea-pig papillary muscles, NIP-142 had no effect on the negative inotropic effect of carbachol under beta-adrenergic stimulation, indicating lack of effect on the muscarinic receptor and Gi protein. These results suggest that NIP-142 directly inhibits the acetylcholine-activated potassium current.

摘要

对NIP-142((3R*,4S*)-4-环丙基氨基-3,4-二氢-2,2-二甲基-6-(4-甲氧基苯乙酰氨基)-7-硝基-2H-1-苯并吡喃-3-醇)这种终止实验性房性心律失常的苯并吡喃化合物的心房特异性动作电位延长作用机制进行了研究。在分离的豚鼠心房组织中,NIP-142逆转了由卡巴胆碱或腺苷诱导的动作电位时程缩短。这些作用可被替地品模拟,但不能被E-4031模拟。NIP-142浓度依赖性地阻断在HEK-293细胞中表达的人G蛋白偶联内向整流钾通道电流(GIRK1/4通道电流),其半数有效浓度(EC50)值为0.64微摩尔。在较高浓度下,NIP-142以44微摩尔的EC50值阻断人去甲肾上腺素能相关基因(HERG)通道电流。在分离的豚鼠乳头肌中,NIP-142在β-肾上腺素能刺激下对卡巴胆碱的负性肌力作用无影响,表明对毒蕈碱受体和Gi蛋白无作用。这些结果提示NIP-142直接抑制乙酰胆碱激活的钾电流。

相似文献

1
Blockade by NIP-142, an antiarrhythmic agent, of carbachol-induced atrial action potential shortening and GIRK1/4 channel.抗心律失常药物NIP-142对卡巴胆碱诱导的心房动作电位缩短和GIRK1/4通道的阻断作用。
J Pharmacol Sci. 2006 Aug;101(4):303-10. doi: 10.1254/jphs.fp0060324. Epub 2006 Aug 5.
2
Atria selective prolongation by NIP-142, an antiarrhythmic agent, of refractory period and action potential duration in guinea pig myocardium.抗心律失常药物NIP-142对豚鼠心肌不应期和动作电位持续时间的心房选择性延长作用。
J Pharmacol Sci. 2005 May;98(1):33-40. doi: 10.1254/jphs.fpj04045x. Epub 2005 May 7.
3
Characterization of in vivo and in vitro electrophysiological and antiarrhythmic effects of a novel IKACh blocker, NIP-151: a comparison with an IKr-blocker dofetilide.新型IKACh阻滞剂NIP-151的体内和体外电生理及抗心律失常作用的表征:与IKr阻滞剂多非利特的比较
J Cardiovasc Pharmacol. 2008 Feb;51(2):162-9. doi: 10.1097/FJC.0b013e31815e854c.
4
K+ channel-opening properties of a novel compound, NIP-121, in guinea pig myocardium as compared with those of cromakalim.
J Cardiovasc Pharmacol. 1995 Oct;26(4):608-13. doi: 10.1097/00005344-199510000-00016.
5
Anticholinergic effects of class III antiarrhythmic drugs in guinea pig atrial cells. Different molecular mechanisms.III类抗心律失常药物对豚鼠心房细胞的抗胆碱能作用。不同的分子机制。
Circulation. 1995 Jun 1;91(11):2834-43. doi: 10.1161/01.cir.91.11.2834.
6
Inhibitory effect of amiodarone on the muscarinic acetylcholine receptor-operated potassium current in guinea pig atrial cells.胺碘酮对豚鼠心房细胞毒蕈碱型乙酰胆碱受体介导的钾电流的抑制作用。
J Pharmacol Exp Ther. 1996 Nov;279(2):617-24.
7
SD-3212, a new class I and IV antiarrhythmic drug: a potent inhibitor of the muscarinic acetylcholine-receptor-operated potassium current in guinea-pig atrial cells.SD - 3212,一种新型I类和IV类抗心律失常药物:豚鼠心房细胞中毒蕈碱型乙酰胆碱受体介导的钾电流的强效抑制剂。
Br J Pharmacol. 1995 Nov;116(6):2750-6. doi: 10.1111/j.1476-5381.1995.tb17237.x.
8
Potassium channel blockade of atrial negative inotropic responses to P1-purinoceptor and muscarinic receptor agonists and to cromakalim.钾通道对心房肌对P1嘌呤受体、毒蕈碱受体激动剂及克罗卡林的负性肌力反应的阻滞作用。
J Cardiovasc Pharmacol. 1993 Feb;21(2):279-88. doi: 10.1097/00005344-199302000-00014.
9
In vitro and in vivo effects of the atrial selective antiarrhythmic compound AVE1231.心房选择性抗心律失常化合物AVE1231的体外和体内效应
J Cardiovasc Pharmacol. 2007 Apr;49(4):197-206. doi: 10.1097/FJC.0b013e318032002f.
10
Effect of NIP-142 on potassium channel alpha-subunits Kv1.5, Kv4.2 and Kv4.3, and mouse atrial repolarization.NIP-142 对钾通道 alpha 亚基 Kv1.5、Kv4.2 和 Kv4.3 以及小鼠心房复极的影响。
Biol Pharm Bull. 2010;33(1):138-41. doi: 10.1248/bpb.33.138.

引用本文的文献

1
Automaticity of the Pulmonary Vein Myocardium and the Effect of Class I Antiarrhythmic Drugs.肺静脉心肌的自律性和 I 类抗心律失常药物的作用。
Int J Mol Sci. 2024 Nov 18;25(22):12367. doi: 10.3390/ijms252212367.
2
Characterization of VU0468554, a New Selective Inhibitor of Cardiac G Protein-Gated Inwardly Rectifying K Channels.VU0468554 是一种新型选择性心脏 G 蛋白门控内向整流钾通道抑制剂的特性研究。
Mol Pharmacol. 2021 Dec;100(6):540-547. doi: 10.1124/molpharm.121.000311. Epub 2021 Sep 9.
3
Kir Channel Molecular Physiology, Pharmacology, and Therapeutic Implications.
Kir 通道的分子生理学、药理学及治疗学意义。
Handb Exp Pharmacol. 2021;267:277-356. doi: 10.1007/164_2021_501.
4
Advances in Targeting GIRK Channels in Disease.疾病中靶向 GIRK 通道的研究进展。
Trends Pharmacol Sci. 2021 Mar;42(3):203-215. doi: 10.1016/j.tips.2020.12.002. Epub 2021 Jan 16.
5
Potassium currents in the heart: functional roles in repolarization, arrhythmia and therapeutics.心脏中的钾电流:在复极化、心律失常及治疗中的功能作用
J Physiol. 2017 Apr 1;595(7):2229-2252. doi: 10.1113/JP272883. Epub 2017 Jan 5.
6
[New developments in the antiarrhythmic therapy of atrial fibrillation].[心房颤动抗心律失常治疗的新进展]
Herzschrittmacherther Elektrophysiol. 2014 Mar;25(1):41-6. doi: 10.1007/s00399-014-0302-1. Epub 2014 Feb 5.
7
Atrial selectivity of antiarrhythmic drugs.抗心律失常药物的心房选择性。
J Physiol. 2013 Sep 1;591(17):4087-97. doi: 10.1113/jphysiol.2013.256115. Epub 2013 Jun 3.
8
Discovery, characterization, and structure-activity relationships of an inhibitor of inward rectifier potassium (Kir) channels with preference for Kir2.3, Kir3.x, and Kir7.1.发现、鉴定内向整流钾 (Kir) 通道抑制剂及其对 Kir2.3、Kir3.x 和 Kir7.1 的结构活性关系。
Front Pharmacol. 2011 Nov 30;2:75. doi: 10.3389/fphar.2011.00075. eCollection 2011.
9
Small-molecule modulators of inward rectifier K+ channels: recent advances and future possibilities.内向整流钾通道小分子调节剂:最新进展与未来可能。
Future Med Chem. 2010 May;2(5):757-74. doi: 10.4155/fmc.10.179.